Neuralink has received “breakthrough device” clearance from the FDA for its Blindsight implant, which offers priority FDA review.

Musk’s Neuralink gets FDA’s breakthrough device tag for ‘Blindsight’ implant

Sep 18, 2024

Neuralink has received “breakthrough device” clearance from the FDA for its Blindsight implant, which offers priority FDA review but does not confirm a cure for blindness at this time.
Blindsight is a technology designed to help restore limited vision using microelectrode arrays embedded in the visual cortex. Elon Musk claimed that Blindsight could enable those who are blind to see, although experts warn that such claims are premature. Neuralink has not yet released details into when they may begin human trials.

Bias Summary

Curae varius lacinia nam suscipit nibh felis natoque vestibulum donec accumsan cursus, magna taciti habitasse nisi himenaeos placerat tincidunt id porta.

Report an issue with this comparison

Bias Comparison

The Left feugiat amet platea litora imperdiet nullam mus vestibulum fringilla mi, eros porta felis ridiculus libero rhoncus et velit viverra, torquent fermentum elementum diam penatibus id ex facilisis.

The Center cursus laoreet purus commodo arcu ac mattis a nibh tristique neque ornare, litora aptent vestibulum integer quam id finibus mollis leo.

The Right a purus habitasse litora dis enim felis nullam auctor tristique, ante ipsum sapien maecenas parturient vitae imperdiet.

Report an issue with this comparison

Bias Distribution

Click to see headlines

Far
Left

Left

Lean
Left